Rallybio financials
$17.22+1.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $212.0K | $222.0K | $212.0K | $212.0K | $212.0K | $38.0K | $299.0K | $299.0K | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $212.0K | $222.0K | $212.0K | $212.0K | $212.0K | $38.0K | $299.0K | $299.0K | $0.00 | $0.00 | $0.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — |
| Operating income | -$5.7M | -$8.7M | -$6.4M | -$6.9M | -$10.1M | -$9.7M | -$11.6M | -$12.1M | -$17.0M | -$19.8M | -$21.1M | -$19.4M |
| Net income | $43.7M | -$8.3M | -$5.9M | $16.0M | -$9.7M | -$9.4M | -$11.0M | -$11.5M | -$16.2M | -$19.0M | -$20.2M | -$18.4M |
| Net margin | — | −3904.7% | −2636.0% | 7554.7% | −4576.9% | −4452.4% | −29063.2% | −3834.8% | −5430.1% | — | — | — |
| Diluted EPS | $7.53 | $-1.46 | — | $2.88 | $-1.73 | $-1.69 | $-1.98 | $-2.08 | $-2.96 | $-3.76 | $-3.98 | $-3.60 |
| EBITDA | -$5.7M | -$8.7M | -$6.4M | -$6.9M | -$10.0M | -$9.6M | -$11.6M | -$12.0M | -$17.0M | -$19.8M | -$21.1M | -$19.3M |
| Operating cash flow | $45.9M | -$8.0M | -$4.7M | -$6.5M | -$8.4M | -$10.2M | -$9.9M | -$13.5M | -$10.4M | -$15.5M | -$11.6M | -$16.5M |
| Free cash flow | $45.9M | -$8.0M | -$4.7M | -$6.5M | -$8.4M | -$10.2M | -$9.9M | -$13.5M | -$10.4M | -$15.5M | -$11.7M | -$16.5M |
| Diluted shares | 5.8M | 5.7M | — | 5.6M | 5.6M | 5.6M | 5.6M | 5.6M | 5.5M | 5.1M | 5.1M | 5.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $92.8M | $41.3M | $31.4M | $32.1M | $9.4M | $14.8M |
| Short-term investments | $0.00 | $5.5M | $23.4M | $27.2M | $36.3M | $39.7M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $98.1M | $54.5M | $62.3M | $67.7M | $51.0M | $58.0M |
| Total liabilities | $3.6M | $4.2M | $4.3M | $4.6M | $5.0M | $3.9M |
| Shareholders' equity | $94.5M | $50.3M | $58.0M | $63.0M | $46.0M | $54.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology